title: Evaluating influenza disease burden during the 2008-2009 and 2009-2010 influenza seasons in Mongolia.
abstract: It is critical to monitor the incidence and clinical characteristics of influenza and its associated hospitalization to understand influenza disease burden. A disease burden study can inform the prioritization of a public health response. However, little is known about the epidemiology and disease burden of influenza in developing countries, including Mongolia. Thus we performed prospective data and sample collection from patients who visited outpatient clinics with influenza-like illness (ILI) and hospitalized patients with severe acute respiratory infections (SARI) in two sites of Mongolia, Baganuur District of Ulaanbaatar and Selenghe Province, from 2008 to 2010. In total, we examined 350 ILI cases during the 2008-2009 influenza epidemic period and 1723 ILI cases during the 2009-2010 influenza epidemic period. We observed the highest ILI incidence per 1000 population in the one to four year age group in Baganuur and in the under one year age group in Selenghe during both periods. Thirteen SARI cases were positive for seasonal influenza A(H1N1) during the 2008-2009 season and 17 SARI cases were positive for pandemic influenza A(H1N1) 2009 during the 2009-2010 season. Among these cases, 84.6% and 58.8% were children under five years of age, respectively, during the 2008-2009 and 2009-2010 seasons. Taken together, children, especially children under five years, had higher influenza infection incidence and hospitalization rate in Mongolia. Although mortality impact also should be considered, we believe that our findings can be useful in formulating an influenza control strategy during influenza epidemic periods in Mongolia.
authors.affiliation: Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan .
authors.forename: Nao
authors.initials: N
authors.lastname: Nukiwa
authors.forename: Alexanderyn
authors.initials: A
authors.lastname: Burmaa
authors.forename: Taro
authors.initials: T
authors.lastname: Kamigaki
authors.forename: Badarchiin
authors.initials: B
authors.lastname: Darmaa
authors.forename: Jigjidsurengiin
authors.initials: J
authors.lastname: Od
authors.forename: Ishiin
authors.initials: I
authors.lastname: Od
authors.forename: Baataryn
authors.initials: B
authors.lastname: Gantsooj
authors.forename: Tsedenbalyn
authors.initials: T
authors.lastname: Naranzul
authors.forename: Sosorbaramyn
authors.initials: S
authors.lastname: Tsatsral
authors.forename: Luvsanbaldangiin
authors.initials: L
authors.lastname: Enkhbaatar
authors.forename: Rentsengiin
authors.initials: R
authors.lastname: Tuul
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Oshitani
authors.forename: Pagbajabyn
authors.initials: P
authors.lastname: Nymadawa
references.citation: Vaccine. 2009 Dec 11;28(2):398-402
references.pmid: 19853073
references.citation: BMC Infect Dis. 2010 Jun 09;10:162
references.pmid: 20534113
references.citation: J Infect Dis. 2006 Nov 1;194 Suppl 2:S82-91
references.pmid: 17163394
references.citation: Arch Virol. 1996;141(8):1553-69
references.pmid: 8856033
references.citation: J Med Virol. 2010 Nov;82(11):1958-65
references.pmid: 20872724
references.citation: Bull World Health Organ. 1973;49(3):219-33
references.pmid: 4546520
references.citation: N Engl J Med. 2002 Dec 26;347(26):2097-103
references.pmid: 12501221
references.citation: Am J Epidemiol. 1981 Mar;113(3):227-35
references.pmid: 6258427
references.citation: Am J Epidemiol. 1967 Sep;86(2):433-41
references.pmid: 6058395
references.citation: BMC Infect Dis. 2009 Oct 15;9:168
references.pmid: 19828051
references.citation: Vaccine. 1999 Jul 30;17 Suppl 1:S19-23
references.pmid: 10471175
references.citation: PLoS One. 2009 Dec 29;4(12):e8452
references.pmid: 20041114